Virion Therapeutics raises $4M to continue work on cancer, viral infection treatments - Technical.ly Philly

Business

Sep. 17, 2018 9:37 am

Virion Therapeutics raises $4M to continue work on cancer, viral infection treatments

The Philly company, a spinout of the Wistar Institute, got backing from Robin Hood Ventures, Keiretsu Forum and Mid-Atlantic Bio Angels Group.

The Wistar Institute.

(Courtesy photo)

Wistar Institute spinout company Virion Therapeutics raised a $4 million angel round, according to an SEC filing.

The immunotherapy company is working on a path to commercialization for a set of vaccines aimed at treating certain types of cancers and chronic viral infections.

Cofounded by Wistar Institute professor Hildegund C.J. Ertl, Andrew Luber and Bernie Rudnick, the company is working on scientific assets that have been backed by some $25 million in grants.

The Philly-based company will use the funds to complete an FDA Investigational New Drug (IND) filing for its lead HPV vaccine candidate, and perform preclinical work on another vaccine for chronic HBV infection.

“We believe our checkpoint inhibitor has significant advantages over other agents in one of the most rapidly growing segments, immuno-oncology,” cofounder and CEO Rudnick said in a statement. “Our goals are to collaborate with major pharmaceutical companies in commercializing our vaccines, save lives and build a desirable business for near term exits with robust investment returns.”

Rudnick is also a member investor of Robin Hood Ventures, which joined the round with $417,000. Mid-Atlantic Bio Angels Group (MABA), Life Science Angels, Keiretsu Forum, Alliance of Angels and Crimson Peak also invested in the round, which the company expects will exceed $5 million upon final closing.

Investor Rena Rosenberg, a Robin Hood Ventures partner who co-led the Virion investment, said the experience of the company’s leadership made the case for the investment.

“If there is a team that is capable of identifying potential solutions in many of these infection-based cancers, this is the group of individuals that you want,” Rosenberg said.

-30-
JOIN THE COMMUNITY, BECOME A MEMBER
Already a member? Sign in here

Advertisement

The University City Science Center supported 149 projects and companies in the last year

How Macquarie blends tech-fueled financial services with global opportunity

This North Philly-based ‘ugly’ produce startup just raised $16.5M

SPONSORED

Philly

How Macquarie blends tech-fueled financial services with global opportunity

Philadelphia, Pa

Inspire

Event Sales Ambassador

Apply Now
Philadelphia, PA

PromptWorks

Director of Product Design

Apply Now
Philadelphia

Perpay

UX Designer

Apply Now

BIO 2019 was in Philly this week. Here’s what you missed

Why Ben Franklin Technology Partners is fighting for more state funding

Old City medtech startup Strados Labs set to hire after raising $1.8M

SPONSORED

Philly

This apprenticeship program is opening the door for candidates with nontraditional backgrounds

Horsham, PA

Penn Mutual

Software Engineer-Java

Apply Now
Philadelphia

Guru Technologies

Senior Front End Engineer

Apply Now
Center City

Inspire

Product Manager – Sales Tools

Apply Now

Sign-up for daily news updates from Technical.ly Philadelphia

Do NOT follow this link or you will be banned from the site!